Wideband transcranial focused ultrasound for imaging, sensing and therapy - description

Active Grant Awarded

Award ID
R01NS144831
Recipient
Awarding agency
Obligated
$449,362

Award facts

Completion date 5% complete
Place of performance
Minneapolis, MN 55455, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded Regents of the University of Minnesota $449,362 on September 9, 2026, under Assistance Listing 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders. The grant, R01NS144831, funds development of a real-time system for monitoring and delivering transcranial focused ultrasound (TFUS) therapies in vivo using dual-mode ultrasound (DMUA) systems. The work builds on a software-defined ultrasound system that provides 3D imaging for stereotaxic guidance, speckle-tracking feedback, closed-loop control at frame rates up to 500 frames per second, and real-time adaptive refocusing. The stated objective is site-specific treatment of brain tumors and neurological disorders, addressing beam distortion through the skull that limits current clinical systems and most preclinical research, which rely on lower frequencies.

Place of performance is Minneapolis, Minnesota 55455. The period of performance runs from the September 9, 2026 award date to an ultimate completion date of June 30, 2030. The award is classified as a grant.

Description

The long-term objective of the proposed research is to develop a site-specific treatment of brain tumors and neurological disorders using transcranial focused ultrasound (TFUS). FUS is unique as a nonionizing modality suitable for delivering spatially localized therapy at depth, which has been demonstrated to provide a range therapeutic effects from mild neuromodulation to ablation. However, TFUS beam distortions through the skull limit its potential. To date, clinical systems and the majority of preclinical research employ relatively low frequency ultrasound to minimize skull distortions. Furthermore, real-time adaptive control of TFUS applica- tion, including refocusing, has not been demonstrated. We have developed a unique software-defined ultrasound (SDUS) system for stereotaxic guidance and controlled delivery of TFUS therapy in both its neuromodulatory and ablative modes. The system employs 3D ultrasound imaging for identifying markers (e.g. bregma, median and lambda suture lines) for stereotaxic guidance. Real-time ultrasound beamforming is streamlined with speckle tracking to monitor the mechanothermal effects of the TFUS application at high frame rates. This feedback has also been shown to enable closed-loop control of TFUS application at frame rates up to 500 frames per second (FPS). In addition, preliminary data demonstrate the feasibility of real-time adaptive refocusing to maximize the focusing gain and direct the focus to the desired target location. Building on our preliminary results, we propose to develop a real-time system for monitoring and delivering transcranial FUS therapies in vivo using dual-mode ultrasound (DMUA) systems. Dmuas are capable of real-time operation in both therapy and imaging modes, providing immediate feedback on TFUS-tissue interactions at the target focus as well as the intervening and SUR- rounding tissues, including the scalp and skull. This has been demonstrated in cadaver human head samples using a clinically-approved DMUA TFUS applicator. We propose to develop imaging methods to characterize of TFUS exposure EX vivo at the target and critical points on the skull, i.e. perform in situ dosimetry (SA 1). This includes the development of a quantitative method to estimate the thermomechanical response due to subthreshold and suprathreshold TFUS application. The quantitative measurement will provide specific feedback for assessing the improvement due to adaptive refocusing, applicator placement or changes in exposure parameters. The approach will be validated in vitro human cadaver head specimens. Finally, we propose to investigate new conformal TFUS applicators based on the spatio-spectral transmission characteristics of the skull bone in the path of the therapeu- TIC beam (SA 2). The new site-specific designs will be implemented for clinical or surgical applications in the treatment of brain cancer and neurological disorders such as epilepsy. The successful completion of the specific aims of the proposed research will bring about a new generation of image-guided TFUS applicators capable of optimizing the focusing gain and localization of the exposure as well as controlling the therapeutic dose at the target in real-time.

Quick answers

Who received award R01NS144831?

R01NS144831 was awarded to Regents Of The University Of Minnesota by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 9, 2026.

How much is award R01NS144831 worth?

$449,362 has been obligated on R01NS144831.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award